Top Section/Ad
Top Section/Ad
Most recent
Pharmaceuticals and energy transition also ripe sectors for M&A
Munich-based company's deal is one of five launched this month
Big deal joins light supply in January
Bankers say deals are still being launched and believe international rivalry can be negotiated
More articles/Ad
More articles/Ad
More articles
-
China Everbright Greentech, an environmental protection service provider under China Everbright International, is testing lenders’ appetite for a HK$800m ($102m) syndicated loan. -
US private placement market participants are expecting a busier time than usual as volatility due to the UK's departure from the European Union pushes borrowers away from the sterling bond market.
-
The US’s Bristol-Myers Squibb (BMS) has picked two banks to provide the debt portion of its $74bn acquisition of biotech firm Celgene, in one of the biggest pharmaceuticals mergers in recent years.
-
The UK’s Ashtead has ramped up the size of its bank facility to $4.1bn, as amend and extend operations continue unabated after the Christmas break.
-
Schuldschein players are not expecting much deal flow this week but most are optimistic that the market is in a better shape than others. A busier first quarter is expected as a consequence.
-
The 2019 loans market is raring to go, but lending officials say that the leveraged loan market needs some strong deals right away to ease the hangover lingering from last year.
